Head and neck squamous cell carcinoma (HNSCC) encompass a group of complex entities
of tumours affecting the aerodigestive upper tract. The main risk factors are strongly related …

Preclinical models of cancer have long been paramount to understanding tumor
development and advancing the treatment of cancer. Creating preclinical models that mimic …

The incidence of human papillomavirus–positive (HPV+) head and neck squamous cell
carcinoma (HNSCC) has surpassed that of cervical cancer and is projected to increase …

The tumor immune microenvironment (TIME) is closely associated with tumor formation,
particularly linked to the human papillomavirus (HPV), and regulates tumor initiation …

The rapid development of immuno-oncology (IO) therapies for multiple types of cancer has
transformed the cancer treatment landscape and brightened the long-term outlook for many …

Abstract Background Immune checkpoint inhibitors (ICIs) for solid tumors, including those
targeting programmed cell death 1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 …

Cancer of mucosal tissues is a major cause of worldwide mortality for which only palliative
treatments are available for patients with late‐stage disease. Engineered cancer vaccines …

Simple Summary According to the latest GLOBOCAN data, head and neck squamous cell
carcinoma (HNSCC) represents the sixth most prevalent human malignancy. Recent studies …

Ovarian cancer (OC) is estimated to kill~ 14,000 women in the United States in 2019.
Current chemotherapies to treat OC initially show therapeutic efficacy but frequently drug …

In this work, we develop a drug-mimicking nanofibrous peptide hydrogel that shows long-
term bioactivity comparable to a small-molecule inhibitor of inducible nitric oxide synthase …